VIC MAHADEVANBoard Member

SHAILENDRA MAHAJANMD of Maxim Ventures (Board Observer)

Advisory Board Members

NELSON SCHILLER, MDUCSF

DOUGLAS JOHNSTON, MDCleveland Clinic

THOMAS KRUMMEL, MDStanford

Investors & Mentors

STEVE KILLELEAChairman of Integrated Research

YOUNG JIN KIMChairman & CEO of Handok Pharma

SUK JIN KIMInvestor & Handok Pharma

ARJUN MALHOTRACo-Founder of HCL & Headstrong

What world renowned cardiologists are saying about HD Steth:

“HD Steth is transforming the way medicine is practiced at the point-of-care setting enhancing the patient experience, saving time and costs while improving outcomes.” Dr. Nelson Schiller, MD, FACC
UCSF

Patient monitoring with HD Steth contributes to the containment of major adverse effects such as heart failure and post-op complications.”Dr. Doug Johnston, MD, FACC
The Cleveland Clinic